Overexpression of Wnt-1 in thyrocytes enhances cellular growth but suppresses transcription of the thyroperoxidase gene via different signaling mechanisms

Journal of Endocrinology

Volumn 193, Issue 1, 2007, Pages 93-106

  Kim, Won Bae ^a,b   Lewis, Christopher J ^a   McCall, Kelly D ^a   Malgor, Ramiro ^a   Kohn, Aimee D ^c   Moon, Randall T ^c   Kohn, Leonard D ^a  

^a OHIO UNIVERSITY   (United States)

^b University of Ulsan College of Medicine   (South Korea)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BETA CATENIN; CYTOSINE; GUANINE; LYMPHOID ENHANCER FACTOR 1; MESSENGER RNA; PROTEIN KINASE C; SERINE; STAT3 PROTEIN; STAUROSPORINE; THYMINE; THYROID PEROXIDASE; THYROTROPIN; TRANSCRIPTION FACTOR 7; TYROSINE; WNT1 PROTEIN;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CELL GROWTH; COMPLEX FORMATION; CONSENSUS SEQUENCE; CONTROLLED STUDY; GENE ACTIVITY; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HORMONE ACTION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; THYROID CELL; TRANSCRIPTION REGULATION;

ANIMALS; BETA CATENIN; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; IODIDE PEROXIDASE; PROMOTER REGIONS (GENETICS); RATS; SIGNAL TRANSDUCTION; THYROID GLAND; THYROTROPIN; TRANSCRIPTION, GENETIC; TRANSFECTION; WNT1 PROTEIN;

EID: 34247357463     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-06-0025     Document Type: Article

References (57)

1. Aza-Blanc P, Di Lauro R & Santisteban P 1993 Identification of a cis-regulatory element and a thyroid-specific nuclear factor mediating the hormonal regulation of rat thyroid peroxidase promoter activity. Molecular Endocrinology 7 1297-1306.
2. Behrens J, von Kries JP, Kuhl M, Bruhn L, Wedlich D, Grosschedl R & Birchmeier W 1996 Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382 638-642.
3. Bidey SP, Lambert A & Robertson WR 1988 Thyroid cell growth, differentiation and function in the FRTL-5 cell line: a survey. Journal of Endocrinological 119 365-376.
4. Bowman T, Garcia R, Turkson J & Jove R 2000 STATs in oncogenesis. Oncogene 19 2474-2488.
5. Cadigan KM & Nusse R 1997 Wnt signaling: a common theme in animal development. Genes and Development 11 3286-3305.
6. Cadigan KM, Jou AD & Nusse R 2002 Wingless blocks bristle formation and morphogenetic furrow progression in the eye through repression of daughterless. Development 129 3393-3402.
7. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N & Russo A 2003 STAT proteins: from normal control of cellular events to tumorigenesis. Journal of Cellular Physiology 197 157-168.
8. Cavallo R, Rubenstein D & Peifer M 1997 Armadillo and dTCF: a marriage made in the nucleus. Current Opinion in Genetics and Development 7 459-466.
9. Cerrato A, Fulciniti F, Avallone A, Benincasa G, Palombini L & Grieco M 1998 Beta- and gamma-catenin expression in thyroid carcinomas. Journal of Pathology 185 267-272.
10. Clevers H 2000 Axin and hepatocellular carcinomas. Nature Genetics 24 206-208.
11. Emami KH, Nguyen C, Ma H, Kim DH, Jeong KW, Eguchi M, Moon KT, Teo JL, Kim HY, Moon SH et al. 2004 A small molecule inhibitor of beta-catenin/CREB-binding protein transcription. PNAS 101 12682-12687.
12. Fabbro D, Di Loreto C, Beltrami CA, Belfiore A, Di Lauro R & Damante G 1994 Expression of thyroid-specific transcription factors TTF-1 and PAX-8 in human thyroid neoplasms. Cancer Research 54 4744-4749.
13. Francis-Lang H, Price M, Polycarpou-Schwarz M & Di Lauro R 1992 Cell-type-specific expression of the rat thyroperoxidase promoter indicates common mechanisms for thyroid-specific gene expression. Molecular and Cellular Biology 12 576-588.
14. Garcia-Rostan G, Tallini G, Herrero A, D'Aquila TG, Carcangiu ML & Rimm DL 1999 Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Research 59 1811-1815.
15. Garcia-Rostan G, Camp RL, Herrero A, Carcangiu ML, Rimm DL & Tallini G 2001 Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. American Journal of Pathology 158 987-996.
16. Gumbiner BM 2000 Regulation of cadherin adhesive activity. Journal of Cell Biology 148 399-404.
17. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B & Kinzler KW 1998 Identification of c-MYC as a target of the APC pathway. Science 281 1509-1512.
18. Helmbrecht K, Kispert A, von Wasielewski R & Brabant G 2001 Identification of a Wnt/beta-catenin signaling pathway in human thyroid cells. Endocrinology 142 5261-5266.
19. Huang SH, Wu JC, Chang KJ, Liaw KY & Wang SM 1999 Expression of the cadherin-catenin complex in well-differentiated human thyroid neoplastic tissue. Thyroid 9 1095-1103.
20. Isozaki O, Kohn LD, Kozak CA & Kimura S 1989 Thyroid peroxidase: rat cDNA sequence, chromosomal localization in mouse, and regulation of gene expression by comparison to thyroglobulin in rat FRTL-5 cells. Molecular Endocrinology 3 1681-1692.
21. Jain N, Zhang T, Kee WH, Li W & Cao X 1999 Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. Journal of Biological Chemistry 274 24392-24400.
22. Jamora C & Fuchs E 2002 Intercellular adhesion, signalling and the cytoskeleton. Nature Cell Biology 4 E101-E108.
23. Kahler RA & Westendorf JJ 2003 Lymphoid enhancer factor-1 and beta-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter. Journal of Biological Chemistry 278 11937-11944.
24. Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M & Moon RT 2004 Mutant frizzled 4 associated with vitreoretinopathy traps wild-type frizzled in the endoplasmic reticulum by oligomerization. Nature Cell Biology 6 52-58.
25. Kikkawa F, Gonzalez FJ & Kimura S 1990 Characterization of a thyroid-specific enhancer located 5.5 kilobase pairs upstream of the human thyroid peroxidase gene. Molecular and Cellular Biology 10 6216-6224.
26. Klein PS & Melton DA 1996 A molecular mechanism for the effect of lithium on development. PNAS 93 8455-8459.
27. Kohn LD, Saji M, Akamizu T, Ikuyama S, Isozaki O, Kohn AD, Santisteban P, Chan JY, Bellur S & Rotella CM 1989 Receptors of the thyroid: the thyrotropin receptor is only the first violinist of a symphony orchestra. Advances in Experimental Medicine and Biology 261 151-209.
28. Kremenevskaja N, von Wasielewski R, Rao AS, Schofl C, Andersson T & Brabant G 2005 Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene 24 2144-2154.
29. McMahon AP & Moon RT 1989 Ectopic expression of the proto-oncogene int-1 in Xenopus embryos leads to duplication of the embryonic axis. Cell 58 1075-1084.
30. 2+ pathways. Oncogene 18 7860-7872.
31. Mizuno K, Gonzalez FJ & Kimura S 1991 Thyroid-specific enhancer-binding protein (T/EBP): cDNA cloning, functional characterization, and structural identity with thyroid transcription factor TTF-1. Molecular and Cellular Biology 11 4927-4933.
32. Moon RT, Kohn AD, De Ferrari GV & Kaykas A 2004 WNT and beta-catenin signalling: diseases and therapies. Nature Reviews Genetics 5 691-701.
33. Morin PJ 1999 Beta-catenin signaling and cancer. Bioessays 21 1021-1030.
34. Mosmann T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65 55-63.
35. Nelson WJ & Nusse R 2004 Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303 1483-1487.
36. van Noort M, Meeldijk J, van der Zee R, Destree O & Clevers H 2002 Wnt signaling controls the phosphorylation status of beta-catenin. Journal of Biological Chemistry 277 17901-17905.
37. Ortiz L, Aza-Blanc P, Zannini M, Cato AC & Santisteban P 1999 The interaction between the forkhead thyroid transcription factor TTF-2 and the constitutive factor CTF/NF-1 is required for efficient hormonal regulation of the thyroperoxidase gene transcription. Journal of Biological Chemistry 274 15213-15221.
38. Park ES, Kim H, Suh JM, Park SJ, You SH, Chung HK, Lee KW, Kwon OY, Cho BY, Kim YK et al. 2000 Involvement of JAK/STAT (Janus kinase/ signal transducer and activator of transcription) in the thyrotropin signaling pathway. Molecular Endocrinology 14 662-670.
39. Payre F, Vincent A & Carreno S 1999 ovo/svb integrates wingless and DER pathways to control epidermis differentiation. Nature 400 271-275.
40. Piepenburg O, Vorbruggen G & Jackle H 2000 Drosophila segment borders result from unilateral repression of hedgehog activity by wingless signaling. Molecular Cell 6 203-209.
41. Polakis P 1997 The adenomatous polyposis coli (APC) tumor suppressor. Biochimica et Biophysica Acta 1332 F127-F147.
42. Polakis P 2000 Wnt signaling and cancer. Genes and Development 14 1837-1851.
43. Polakis P 2002 Casein kinase 1: a Wnt'er of disconnect. Current Biology 12 R499-R501.
44. Saji M, Shong M, Napolitano G, Palmer LA, Taniguchi SI, Ohmori M, Ohta M, Suzuki K, Kirshner SL, Giuliani C et al. 1997 Regulation of major histocompatibility complex class I gene expression in thyroid cells, role of the cAMP response element-like sequence. Journal of Biological Chemistry 272 20096-20107.
45. Sheldahl LC, Park M, Malbon CC & Moon RT 1999 Protein kinase C is differentially stimulated by Wnt and frizzled homologs in a G-protein-dependent manner. Current Biology 9 695-698.
46. Shimura H, Okajima F, Ikuyama S, Shimura Y, Kimura S, Saji M & Kohn LD 1994 Thyroid-specific expression and cyclic adenosine 3′,5′-monophosphate autoregulation of the thyrotropin receptor gene involves thyroid transcription factor-1. Molecular Endocrinology 8 1049-1069.
47. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R & Ben-Ze'ev A 1999 The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. PNAS 96 5522-5527.
48. Slusarski DC, Corces VG & Moon PT 1997 Interaction of Wnt and a frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature 390 410-413.
49. Suzuki K, Lavaroni S, Mori A, Ohta M, Saito J, Pietrarelli M, Singer DS, Kimura S, Katoh R, Kawaoi A et al. 1998 Autoregulation of thyroid-specific gene transcription by thyroglobulin. PNAS 95 8251-8256.
50. Suzuki K, Mori A, Ishii KJ, Saito J, Singer DS, Klinman DM, Krause PR & Kohn LD 1999 Activation of target-tissue immune-recognition molecules by double-stranded polynucleotides. PNAS 96 2285-2290.
51. Tetsu O & McCormick F 1999 Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 422-426.
52. Webster MT, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC & Wooster R 2000 Sequence variants of the axin gene in breast, colon, and other cancers: an analysis of mutations that interfere with GSK3 binding. Genes, Chromosomes and Cancer 28 443-453.
53. van de Wetering M, Cavallo R, Dooijes D, van Beest M, van Es J, Loureiro J, Ypma A, Hursh D, Jones T, Bejsovec A et al. 1997 Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell 88 789-799.
54. Yang X, van Beest M, Clevers H, Jones T, Hursh DA & Mortin MA 2000 Decapentaplegic is a direct target of dTcf repression in the Drosophila visceral mesoderm. Development 127 3695-3702.
55. Yang-Snyder J, Miller JR, Brown JD, Lai CJ & Moon RT 1996 A frizzled homolog functions in a vertebrate Wnt signaling pathway. Current Biology 6 1302-1306.
56. Yost C, Torres M, Miller JR, Huang E, Kimelman D & Moon RT 1996 The axis-inducing activity, stability and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes and Development 10 1443-1454.
57. Zannini M, Francis-Lang H, Plachov D & Di Lauro R 1992 Pax-8, a paired domain-containing protein, binds to a sequence overlapping the recognition site of a homeodomain and activates transcription from two thyroid-specific promoters. Molecular and Cellular Biology 12 4230-4241.